Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evacetrapib Monotherapy in Japanese Patients with Primary Hypercholesterolemia
NCT02260635Phase 3Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of evacetrapib in hypercholesterolemia, sponsored by Eli Lilly and Company. Started Nov 2014; status: terminated.
02
Drugs
evacetrapib
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02260635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260635.